2604.02062 AlphaFold 3 Drug-Target Predictor: Structure-Based Hypothesis Generation
This protocol combines AlphaFold 3 protein structure prediction with binding site identification and ligand analysis for structure-based drug discovery. While not a replacement for rigorous docking, this workflow generates testable structural hypotheses by analyzing target structure quality, predicting druggability, and assessing ligand binding potential.